Clinical Image, J Food Nutr Disord Vol: 6 Issue: 4
Distal Migration of Percutaneous Endoscopic Gastrostomy Tube Causing Gastric Outlet Obstruction
Gravito-Soares M1*, Gravito-Soares E1, Almeida N1,2 and Tomé 1,2
1Department of Gastroenterology, Coimbra University Hospital, Coimbra,Portugal
2Faculty of Medicine, University of Coimbra, Coimbra, Portugal
*Corresponding Author : Marta Gravito-Soares
Department of Gastroenterology, Coimbra University Hospital, Coimbra, Portugal, Postal address: Praceta Prof. Mota Pinto, 3000-075 Coimbra, Portugal
Tel: 239 400 483
Fax: 239 701 517
E-mail: ms18498@gmail.com
Received: July 19, 2017 Accepted: August 04, 2017 Published: August 09, 2017
Citation: Gravito-Soares M, Gravito-Soares E, Almeida N, Tomé L (2017) Distal Migration of Percutaneous Endoscopic Gastrostomy Tube causing Gastric Outlet Obstruction. J Food Nutr Disord 6:4. doi: 10.4172/2324-9323.1000233
Abstract
An 80-year-old woman has been carrying percutaneous endoscopy gastrostomy (PEG) 20Fr for 3 years due to post-stroke dysphagia. She complains of 2 months of vomiting and recurrent abdominal pain. Analyses were unremarkable. Plain abdominal X-ray revealed hidroaereal levels and distention of the bowel loops. Abdominal CT showed concentric thickening of the antrum of oedematous nature, the PEG balloon at the duodenum first portion without pneumoperitoneum (Figure 1). The PEG was functional with easy rotation, but only with possible traction up to the 7 cm mark. After gastric content aspiration, the esophagogastroduodenoscopy showed duodenal migration of the PEG balloon causing gastric drainage obstruction (Figure 2) and duodenal bulb erosions by PEG balloon trauma. The PEG tube was repositioned at the level of the gastrocutaneous fistula after deflation of the balloon (Figure 3A) and then reinflated with 20 mL of distilled water. Additionally, a second external fixator was placed 3.5cm from the anterior abdominal wall to avoid recurrence of this complication (Figure 3B). No PEG migration recurrence was verified during 11 months of follow-up.